- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.69 Å
- Oligo State
- hetero-4-4-4-mer
- Ligands
- 4 x F09: NONAN-1-OL(Non-covalent)
- 4 x 1EM: (1S)-2-HYDROXY-1-[(NONANOYLOXY)METHYL]ETHYL MYRISTATE(Non-covalent)
1EM.2: 9 residues within 4Å:- Chain C: V.59, L.61, R.64
- Chain L: S.19, Y.37, P.38, R.39, L.41, V.45
6 PLIP interactions:2 interactions with chain C, 4 interactions with chain L- Hydrophobic interactions: C:L.61, L:Y.37, L:P.38, L:V.45
- Salt bridges: C:R.64
- Hydrogen bonds: L:R.39
1EM.10: 9 residues within 4Å:- Chain F: V.59, L.61, R.64
- Chain I: S.19, Y.37, P.38, R.39, L.41, V.45
6 PLIP interactions:4 interactions with chain I, 2 interactions with chain F- Hydrophobic interactions: I:Y.37, I:P.38, I:V.45, F:L.61
- Hydrogen bonds: I:R.39
- Salt bridges: F:R.64
1EM.18: 9 residues within 4Å:- Chain C: S.19, Y.37, P.38, R.39, L.41, V.45
- Chain I: V.59, L.61, R.64
6 PLIP interactions:4 interactions with chain C, 2 interactions with chain I- Hydrophobic interactions: C:Y.37, C:P.38, C:V.45, I:L.61
- Hydrogen bonds: C:R.39
- Salt bridges: I:R.64
1EM.26: 9 residues within 4Å:- Chain F: S.19, Y.37, P.38, R.39, L.41, V.45
- Chain L: V.59, L.61, R.64
6 PLIP interactions:2 interactions with chain L, 4 interactions with chain F- Hydrophobic interactions: L:L.61, F:Y.37, F:P.38, F:V.45
- Salt bridges: L:R.64
- Hydrogen bonds: F:R.39
- 24 x K: POTASSIUM ION(Non-functional Binders)(Non-covalent)
K.3: 3 residues within 4Å:- Ligands: K.11, K.19, K.27
Ligand excluded by PLIPK.4: 7 residues within 4Å:- Chain C: T.50
- Chain F: T.50
- Chain I: T.50
- Chain L: T.50
- Ligands: K.12, K.20, K.28
Ligand excluded by PLIPK.5: 11 residues within 4Å:- Chain C: G.52, Y.53
- Chain F: G.52, Y.53
- Chain I: G.52, Y.53
- Chain L: G.52, Y.53
- Ligands: K.13, K.21, K.29
Ligand excluded by PLIPK.6: 7 residues within 4Å:- Ligands: K.7, K.14, K.15, K.22, K.23, K.30, K.31
Ligand excluded by PLIPK.7: 7 residues within 4Å:- Ligands: K.6, K.14, K.15, K.22, K.23, K.30, K.31
Ligand excluded by PLIPK.8: 11 residues within 4Å:- Chain C: T.50, V.51
- Chain F: T.50, V.51
- Chain I: T.50, V.51
- Chain L: T.50, V.51
- Ligands: K.16, K.24, K.32
Ligand excluded by PLIPK.11: 3 residues within 4Å:- Ligands: K.3, K.19, K.27
Ligand excluded by PLIPK.12: 7 residues within 4Å:- Chain C: T.50
- Chain F: T.50
- Chain I: T.50
- Chain L: T.50
- Ligands: K.4, K.20, K.28
Ligand excluded by PLIPK.13: 11 residues within 4Å:- Chain C: G.52, Y.53
- Chain F: G.52, Y.53
- Chain I: G.52, Y.53
- Chain L: G.52, Y.53
- Ligands: K.5, K.21, K.29
Ligand excluded by PLIPK.14: 7 residues within 4Å:- Ligands: K.6, K.7, K.15, K.22, K.23, K.30, K.31
Ligand excluded by PLIPK.15: 7 residues within 4Å:- Ligands: K.6, K.7, K.14, K.22, K.23, K.30, K.31
Ligand excluded by PLIPK.16: 11 residues within 4Å:- Chain C: T.50, V.51
- Chain F: T.50, V.51
- Chain I: T.50, V.51
- Chain L: T.50, V.51
- Ligands: K.8, K.24, K.32
Ligand excluded by PLIPK.19: 3 residues within 4Å:- Ligands: K.3, K.11, K.27
Ligand excluded by PLIPK.20: 7 residues within 4Å:- Chain C: T.50
- Chain F: T.50
- Chain I: T.50
- Chain L: T.50
- Ligands: K.4, K.12, K.28
Ligand excluded by PLIPK.21: 11 residues within 4Å:- Chain C: G.52, Y.53
- Chain F: G.52, Y.53
- Chain I: G.52, Y.53
- Chain L: G.52, Y.53
- Ligands: K.5, K.13, K.29
Ligand excluded by PLIPK.22: 7 residues within 4Å:- Ligands: K.6, K.7, K.14, K.15, K.23, K.30, K.31
Ligand excluded by PLIPK.23: 7 residues within 4Å:- Ligands: K.6, K.7, K.14, K.15, K.22, K.30, K.31
Ligand excluded by PLIPK.24: 11 residues within 4Å:- Chain C: T.50, V.51
- Chain F: T.50, V.51
- Chain I: T.50, V.51
- Chain L: T.50, V.51
- Ligands: K.8, K.16, K.32
Ligand excluded by PLIPK.27: 3 residues within 4Å:- Ligands: K.3, K.11, K.19
Ligand excluded by PLIPK.28: 7 residues within 4Å:- Chain C: T.50
- Chain F: T.50
- Chain I: T.50
- Chain L: T.50
- Ligands: K.4, K.12, K.20
Ligand excluded by PLIPK.29: 11 residues within 4Å:- Chain C: G.52, Y.53
- Chain F: G.52, Y.53
- Chain I: G.52, Y.53
- Chain L: G.52, Y.53
- Ligands: K.5, K.13, K.21
Ligand excluded by PLIPK.30: 7 residues within 4Å:- Ligands: K.6, K.7, K.14, K.15, K.22, K.23, K.31
Ligand excluded by PLIPK.31: 7 residues within 4Å:- Ligands: K.6, K.7, K.14, K.15, K.22, K.23, K.30
Ligand excluded by PLIPK.32: 11 residues within 4Å:- Chain C: T.50, V.51
- Chain F: T.50, V.51
- Chain I: T.50, V.51
- Chain L: T.50, V.51
- Ligands: K.8, K.16, K.24
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Reddi, R. et al., Structures of Gating Intermediates in a K + channell. J.Mol.Biol. (2021)
- Release Date
- 2021-10-27
- Peptides
- Monoclonal antibody (IgG) against KcsA, Fab heavy chain: ADGJ
Monoclonal antibody (IgG) against KcsA, Fab light chain: BEHK
pH-gated potassium channel KcsA: CFIL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
AG
AJ
AB
BE
BH
BK
BC
CF
CI
CL
C - Membrane
-
We predict this structure to be a membrane protein.
SMTL ID : 7m2i.1
Structural Snapshots of Intermediates in the Gating of a K+ Channel
Monoclonal antibody (IgG) against KcsA, Fab heavy chain
Toggle Identical (ADGJ)Monoclonal antibody (IgG) against KcsA, Fab light chain
Toggle Identical (BEHK)pH-gated potassium channel KcsA
Toggle Identical (CFIL)Related Entries With Identical Sequence
1k4c.1 | 1k4d.1 | 1r3i.1 | 1r3j.1 | 1r3k.1 | 1r3l.1 | 1s5h.1 | 1zwi.1 | 2atk.1 | 2bob.1 | 2boc.1 | 2dwd.1 | 2dwe.1 | 2h8p.1 | 2hfe.1 | 2hg5.1 | 2hjf.1 | 2hvj.1 | 2hvk.1 | 2ih1.1 | 2ih3.1 | 2itc.1 | 2itd.1 | 2jk5.1 | 2nlj.1 | 2p7t.2 | 2p7t.3 | 2w0f.1 | 3f5w.1 | 3f7v.1 more...less...3f7v.2 | 3f7y.1 | 3f7y.2 | 3fb5.1 | 3fb5.2 | 3fb6.1 | 3fb6.2 | 3fb7.1 | 3fb7.2 | 3fb8.1 | 3fb8.2 | 3fb8.3 | 3gb7.1 | 3hpl.1 | 3iga.1 | 3ogc.1 | 3or6.1 | 3or7.1 | 3stl.1 | 3stz.1 | 4lbe.1 | 4lcu.1 | 4msw.1 | 4uuj.1 | 5e1a.1 | 5ebl.1 | 5ebm.1 | 5ec1.1 | 5ec2.1 | 5j9p.1 | 5vk6.1 | 5vke.1 | 5vkh.1 | 6by2.1 | 6by3.1 | 6nfu.1 | 6nfv.1 | 6pa0.1 | 6w0a.1 | 6w0b.1 | 6w0c.1 | 6w0d.1 | 6w0e.1 | 6w0f.1 | 6w0g.1 | 6w0h.1 | 6w0i.1 | 6w0j.1 | 7m2h.1 | 7m2h.2 | 7m2j.1 | 7mhr.1 | 7mhx.1 | 7rp0.1 | 7sqw.1 | 8thn.1